HYMPAVZI® (MARSTACIMAB) REDUCED BLEEDS BY 93% COMPARED TO ON-DEMAND TREATMENT IN ADULTS AND ADOLESCENTS WITH HEMOPHILIA A OR B WITH INHIBITORS

Reuters · 1d ago

Please log in to view news